
Suraj Shriniwas Zanwar
About Suraj Shriniwas Zanwar
Data last updated:
Suraj Shriniwas Zanwar was a Managing Director at Cian Healthcare Limited (from 2003), Director at Dr. Smiths Biotech Private Limited (from 2015) and Partner at Unilink Marketing Llp (from 2019).
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 07 Jan 2003 | 2003 | ₹62.14 Cr (FY 2024) | Under Cirp | |
| Director | 24 Apr 2015 | 2015 | ₹22.70 Cr (FY 2023) | Under Cirp | |
| Partner | 06 Nov 2019 | 2017 | Converted To Cmp And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suraj Shriniwas Zanwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suraj Shriniwas Zanwar
Suraj Shriniwas Zanwar was first appointed on 07 Jan 2003 as Managing Director at Cian Healthcare Limited. The most recent appointment on record is 06 Nov 2019 at Unilink Marketing Llp.
Suraj Shriniwas Zanwar held 3 earlier board appointments: Cian Healthcare Limited (Managing Director, from 07 Jan 2003); Dr. Smiths Biotech Private Limited (Director, from 24 Apr 2015); Unilink Marketing Llp (Partner, from 06 Nov 2019).